GET DAILY SIGNALSHIVE (HIVE) vs RIOT (RIOT): Weighing Their Shifts From Bitcoin Mining to AI Infrastructure
Key Takeaways
- Both HIVE and RIOT are Bitcoin miners moving into AI and HPC data center revenue, though they are doing so at very different scales and on different timelines.
- HIVE holds a "Strong Buy" sell-side consensus and has turned AI cloud contracts into nearer-term contracted revenue more directly than its peer.
- RIOT maintains a larger power portfolio and a multi-billion-dollar AI lease, but the payoff sits further out behind substantial capital spending and funding that remains incomplete.
- Tickeron AI Verdict: HIVE stands out as the preferred name right now, thanks to cleaner trend consistency, closer-term contracted catalysts, and a more immediate AI revenue ramp compared with RIOT’s longer-dated, funding-dependent buildout.
- For additional background, review HIVE Major News and HIVE Today's Price Move, along with RIOT Major News and RIOT Today's Price Move.
Setting the Stage
HIVE Digital Technologies and Riot Platforms find themselves at the crossroads of two prominent market themes: Bitcoin mining and AI infrastructure. Both are working to reduce pure cryptocurrency exposure by repurposing power and data center assets for AI and HPC workloads. This comparison matters most to investors weighing relative performance, positioning, and execution risk between a smaller, green-energy operator and a larger Texas-based miner with a sizable power base. Understanding how the two diverge in scale, catalysts, and capital needs helps clarify which presents the more attractive risk-reward balance today.
HIVE Overview and Recent Performance
HIVE Digital Technologies develops and runs data centers powered by green energy in Canada, Sweden, and Paraguay. It follows a dual strategy that pairs Bitcoin mining with a growing HPC/AI cloud business under the BUZZ brand. Recent sentiment has been shaped by a five-year GPU cloud agreement worth roughly $350 million that will deploy NVIDIA Blackwell Ultra GPUs. The arrangement has pushed BUZZ HPC’s contracted annualized revenue toward $180 million, bringing the company closer to its $200 million GPU cloud ARR goal.
That progress has been offset by dilution worries. HIVE has renewed an at-the-market equity program and issued exchangeable notes to support expansion, and it remains unprofitable on an EPS basis even as revenue rises. Recent trading has shown this tension, with the stock pulling back from prior highs despite a positive analyst consensus. The smaller market capitalization leaves HIVE more exposed to both AI contract news and Bitcoin price moves, which adds to volatility.
RIOT Overview and Recent Performance
Riot Platforms operates as a vertically integrated Bitcoin miner with large facilities in Texas and Kentucky, plus an engineering business that produces electrical equipment. Its standout development is the move into AI data center hosting via a roughly 20-year, $9.1 billion lease for 191 megawatts at the Rockdale campus, reportedly with a leading frontier AI lab, plus a smaller AMD hosting deal. These agreements have shifted the narrative toward AI infrastructure.
The benefits remain back-loaded, however. RIOT does not expect the first phase of the Rockdale project until late next year, and the full effort requires an estimated $2.1 billion to $2.3 billion in capital that is not yet fully secured. The company has used an interim credit facility while seeking an investment-grade backstop. Over the past twelve months it posted a sizable net loss, and mining margins stay sensitive to Bitcoin prices and network difficulty. These elements have kept the stock range-bound and volatile, with some analysts recently lowering price targets even as ratings stayed constructive overall.
Head-to-Head Comparison
The clearest differences appear in scale and capital intensity. RIOT runs a much larger power portfolio of about 1.7 gigawatts across its Texas sites, and its $9.1 billion AI lease far exceeds HIVE’s individual contracts. That size also brings heavier funding needs and a longer wait before revenue turns into cash flow. HIVE’s AI agreements, though smaller, are already generating recurring revenue and benefit from upfront customer deposits.
Both companies rely on AI demand and Bitcoin prices, yet HIVE has emphasized sovereign AI and green-powered Canadian sites while RIOT highlights its power-dense Texas footprint. Risk profiles differ as well: HIVE faces dilution from equity and convertible financing, whereas RIOT carries more debt and may need to sell Bitcoin to help fund expansion. Market sentiment favors HIVE with a stronger consensus rating, while RIOT’s outlook depends on delivering one large infrastructure project.
Tickeron AI Verdict
Based on the factors at hand, Tickeron’s AI currently leans toward HIVE. The view rests more on relative positioning than absolute size: HIVE shows cleaner trend consistency, a faster route to contracted AI revenue, and a solidly positive analyst consensus, even though both firms remain unprofitable. RIOT’s opportunity may be larger in theory, but it involves greater execution and financing uncertainty, with its main catalyst still years away and tied to securing long-term capital. In probabilistic terms, HIVE’s nearer-term drivers and less capital-heavy path give it a comparatively better setup in the present environment. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Exploring AI Tools for Market Analysis
When evaluating names like these, I sometimes turn to Tickeron’s Trending AI Robots to see how automated strategies are positioned. The section curates bots with approaches that match current conditions, whether trend-following or momentum-based, and offers a practical way to gauge how data-driven systems are handling volatility across similar tickers.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
HIVE's RSI Indicator dives into oversold zone
The RSI Oscillator for HIVE moved into overbought territory on October 30, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 54 of 64 cases where HIVE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for HIVE just turned positive on October 29, 2026. Looking at past instances where HIVE's MACD turned positive, the stock continued to rise in 30 of 38 cases over the following month. The odds of a continued upward trend are 79%.
Following a +11.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where HIVE advanced for three days, in 213 of 255 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HIVE as a result. In 69 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
HIVE moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HIVE crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
The 50-day moving average for HIVE moved below the 200-day moving average on October 16, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIVE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for HIVE entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.972) is normal, around the industry mean (3.108). P/E Ratio (9.174) is within average values for comparable stocks, (6.904). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (7.800) among similar stocks. P/S Ratio (2.169) is also within normal values, averaging (16.899).
The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. HIVE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of cloud networking and enterprise Wi-Fi solution
Industry InvestmentBanksBrokers
Advertisement